These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14622931)

  • 1. Tritiation of nonpeptide substance P antagonist CP-96,345 and its azido analogue. Synthetic and characterization details.
    Egan JA; Filer CN
    Appl Radiat Isot; 2003; 59(5-6):333-5. PubMed ID: 14622931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist.
    MacDonald D; Silberman SC; Lowe JA; Drozda SE; Leeman SE; Boyd ND
    Mol Pharmacol; 1996 May; 49(5):808-13. PubMed ID: 8622630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tritium labelling and characterization of the potent imidazoline I1 receptor antagonist [5,7-3H] (+/-)-efaroxan at high specific activity.
    Egan JA; Filer CN
    Appl Radiat Isot; 2003 Jun; 58(6):675-7. PubMed ID: 12798376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studies.
    Del Rosario RB; Mangner TJ; Gildersleeve DL; Shreve PD; Weiland DM; Lowe JA; Drozda SE; Snider RM
    Nucl Med Biol; 1993 May; 20(4):545-7. PubMed ID: 7684941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colforsin analogues: tritiation and characterization.
    Egan JA; Nugent RP; Filer CN
    Appl Radiat Isot; 2004 Dec; 61(6):1269-72. PubMed ID: 15388120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tritium labelling of dopaminergic ligands domperidone and (+/-)-7-hydroxy DPAT.
    Pounds S; Seguin RJ; Filer CN
    Appl Radiat Isot; 2005 Jan; 62(1):49-53. PubMed ID: 15498684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tritiation of azido-labeled diiodo cabazitaxel (Jevtana) and docetaxel (Taxotere) derivatives to generate
    Jones S; Weck R; Burhop A; Atzrodt J; Derdau V
    J Labelled Comp Radiopharm; 2018 Oct; 61(12):895-902. PubMed ID: 30101475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis of a tritium, carbon-14, and stable isotope-labeled cathepsin C inhibitors.
    Allen P; Bragg RA; Caffrey M; Ericsson C; Hickey MJ; Kingston LP; Elmore CS
    J Labelled Comp Radiopharm; 2017 Feb; 60(2):124-129. PubMed ID: 27868229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tritiation and characterization of several suicide substrate enzyme inactivators.
    Egan JA; Filer CN
    Appl Radiat Isot; 2014 Dec; 94():302-305. PubMed ID: 25305521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.
    Schmidt AW; McLean S; Heym J
    Eur J Pharmacol; 1992 Sep; 219(3):491-2. PubMed ID: 1385177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethyl-³H analogues of plant natural products: Biologically active proxy radioligands via vinyl group tritiation.
    Orphanos D; Filer CN
    Appl Radiat Isot; 2016 Jan; 107():203-205. PubMed ID: 26520478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu opiate active substances trefentanil and naloxonazine: tritiation at high specific activity.
    Ahern DG; Egan JA; Seguin RJ; Filer CN
    Appl Radiat Isot; 2005 Aug; 63(2):189-92. PubMed ID: 15927477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of [15, 16- ³H] beta-funaltrexamine.
    Filer CN; Seguin RJ
    J Labelled Comp Radiopharm; 2013 May; 56(5):310-1. PubMed ID: 24285378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palladium(II)-Mediated C-H Tritiation of Complex Pharmaceuticals.
    Yang H; Dormer PG; Rivera NR; Hoover AJ
    Angew Chem Int Ed Engl; 2018 Feb; 57(7):1883-1887. PubMed ID: 29314462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDV3100: Tritium labeling at high specific activity.
    Byon C; Chakravarty S; Filer CN; Jain R; Maniscalco MP
    Appl Radiat Isot; 2016 Feb; 108():35-37. PubMed ID: 26686973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst.
    Lowe JA; Drozda SE; Snider RM; Longo KP; Zorn SH; Morrone J; Jackson ER; McLean S; Bryce DK; Bordner J
    J Med Chem; 1992 Jul; 35(14):2591-600. PubMed ID: 1378901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and characteristics of a tritiated derivative of CP-96,345--a nonpeptide antagonist of the substance P receptor with a high specific radioactivity].
    Kasheverov IE; Zaĭtsev DA; Utkin IuN; Tsetlin VI
    Bioorg Khim; 1994 Nov; 20(11):1162-8. PubMed ID: 7880176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphinan alkaloids labeled with tritium: synthesis and applications.
    Filer CN
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):639-48. PubMed ID: 25196025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of tritium-labelled N tau-methylhistamine for the improvement of extraction efficiency of N tau-methylhistamine from biological fluids.
    Iwashina T; Scott PG; Tredget EE
    Appl Radiat Isot; 1997 Sep; 48(9):1187-91. PubMed ID: 9418210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tritiation of several antihypertensive agents at high specific activity.
    Andrews JR; Egan JA; Filer CN
    Appl Radiat Isot; 2008 Oct; 66(10):1392-5. PubMed ID: 18424053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.